Marek David C 4
4 · Myovant Sciences Ltd. · Filed Jan 21, 2022
Insider Transaction Report
Form 4
Marek David C
DirectorPrincipal Executive Officer
Transactions
- Sale
Common Shares
2022-01-19$14.68/sh−19,882$291,868→ 337,983 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.